Journal of Occupational
Health and Epidemiology
Rafsanjan university Of medical sciences
Volume 13, Issue 2 (Spring 2024)
J Occup Health Epidemiol 2024, 13(2): 70-75 |
Back to browse issues page
Ethics code: IR.MUBAM.REC.1400.049
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghasemi M, Khosravi S, Malekyan L, Faridi A, Abedi Gheshlaghi L, Sobhanipoor M H et al . Side Effects of Sputnik V, Sinopharm, and AstraZeneca COVID-19 Vaccines among Healthcare Workers. J Occup Health Epidemiol 2024; 13 (2) :70-75
URL: http://johe.rums.ac.ir/article-1-768-en.html
URL: http://johe.rums.ac.ir/article-1-768-en.html
Related article in
Google Scholar
Google Scholar
Similar articles
Masoomeh Ghasemi1 
, Sajad Khosravi2 , Leila Malekyan3 , Amin Faridi4 , Leili Abedi Gheshlaghi5 , Mohammad Hossein Sobhanipoor1 , Elham Isaei * 6
, Sajad Khosravi2 , Leila Malekyan3 , Amin Faridi4 , Leili Abedi Gheshlaghi5 , Mohammad Hossein Sobhanipoor1 , Elham Isaei * 6
1- Associated Prof., Medicine School, Bam University of Medical Sciences, Bam, Iran.
2- Associated Prof., Dept. of Health Management, Policy and Economics, School of Public Health, Bam University of Medical Sciences, Bam, Iran. & Associated Prof., Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
3- Instructor of Nursing, Dept. of Nursing, School of Nursing and Midwifery, Bam University of Medical Sciences, Bam, Iran.
4- M.D., Medicine School, Bam University of Medical Sciences, Bam, Iran.
5- Associated Prof., Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
6- Associated Prof., Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran. ,eli1989.isaei@gmail.com
2- Associated Prof., Dept. of Health Management, Policy and Economics, School of Public Health, Bam University of Medical Sciences, Bam, Iran. & Associated Prof., Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
3- Instructor of Nursing, Dept. of Nursing, School of Nursing and Midwifery, Bam University of Medical Sciences, Bam, Iran.
4- M.D., Medicine School, Bam University of Medical Sciences, Bam, Iran.
5- Associated Prof., Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
6- Associated Prof., Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran. ,
Article history
Received: 2023/07/16
Accepted: 2024/02/23
ePublished: 2024/06/26
Accepted: 2024/02/23
ePublished: 2024/06/26
Subject:
Epidemiology
Abstract: (155 Views)
Background: Vaccines during the pandemic COVID-19 were the best solution to overcome the pandemic. The aim of this study was to evaluate and compare Sputnik V, Sinopharm, and AstraZeneca vaccins’ side effects.
Material and Methods: A cross-sectional study was designed among healthcare workers in a teaching hospital. The checklist was prepared for collecting data of demographic variables, respondents’ medical history, and vaccines side effects.
Results: More than half of participants received Sinopharm, while the development of COVID-19 following AstraZeneca was significantly among smaller proportion of respondents than other vaccines (P< 0.0001). There was no significant difference between age group and general side effects. The prevalence of serious side effects was higher in healthcare workers younger than 40 years old (P< 0.0001). The emergence of oral side effects was higher in participants who received two doses of vaccines in comparison to individuals who received one dose (P< 0.0001).
Conclusion: The prevalence of serious side effects was higher in sputnik V in comparison to the other vaccines. The vaccines serious side effects were linked to the age of vaccinated people and immune system responses.
Material and Methods: A cross-sectional study was designed among healthcare workers in a teaching hospital. The checklist was prepared for collecting data of demographic variables, respondents’ medical history, and vaccines side effects.
Results: More than half of participants received Sinopharm, while the development of COVID-19 following AstraZeneca was significantly among smaller proportion of respondents than other vaccines (P< 0.0001). There was no significant difference between age group and general side effects. The prevalence of serious side effects was higher in healthcare workers younger than 40 years old (P< 0.0001). The emergence of oral side effects was higher in participants who received two doses of vaccines in comparison to individuals who received one dose (P< 0.0001).
Conclusion: The prevalence of serious side effects was higher in sputnik V in comparison to the other vaccines. The vaccines serious side effects were linked to the age of vaccinated people and immune system responses.
References
1. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines : Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1-9. [DOI] [PMID]
2. Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021;21(1):39-51. [DOI] [PMID] [PMCID]
3. Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 : an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111. [DOI] [PMID] [PMCID]
4. Ghiasi N, Valizadeh R, Arabsorkhi M, Hoseyni TS, Esfandiari K, Sadighpour T, et al. Efficacy and side effects of Sputnik V , Sinopharm and AstraZeneca vaccines to stop COVID-19 ; a review and discussion. Immunopathol Persa. 2021;7(2):e31. [DOI]
5. Nagy A, Alhatlani B. An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J. 2021;19:2508-17. [DOI] [PMID] [PMCID]
6. Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, et al. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines (Basel). 2021;9(6):674. [DOI] [PMID] [PMCID]
7. Attash HM, Al-Obaidy LM, Al-Qazaz HK. Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects ? A Retrospective Cross-Sectional Study. Vaccines (Basel). 2022;10(2):186. [DOI] [PMID] [PMCID]
8. Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J Clin Med. 2021;10(7):1428. [DOI] [PMID] [PMCID]
9. Jahan N, Rahman FI, Saha P, Ether SA, Roknuzzaman A, Sarker R, et al. Side Effects Following Administration of the First Dose of Oxford-AstraZeneca's Covishield Vaccine in Bangladesh : A Cross-Sectional Study. Infect Dis Rep. 2021;13(4):888-901. [DOI] [PMID] [PMCID]
10. Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, et al. Adverse effects following COVID ‑ 19 vaccination in Iran. BMC Infect Dis. 2022;22(1):1-8. [DOI] [PMID] [PMCID]
11. Public Health Ontario. Adverse Events Following Immunization (AEFIs) for COVID-19 in Ontario: December 13, 2020 to May 19, 2024. Toronto, ON: King’s Printer for Ontario; 2024. [Report]
12. Butbul Aviel Y, Hashkes PJ, Dizitzer Y, Inbar K, Berkun Y, Eisenstein EM, et al. Case Series of Myocarditis Following mRNA COVID Vaccine Compared to Pediatric Multisystem Inflammatory Syndrome : Multicenter Retrospective Study. Vaccines (Basel). 2022;10(8):1207. [DOI] [PMID] [PMCID]
13. Elgendy MO, El-Gendy AO, Mahmoud S, Mohammed TY, Abdelrahim MEA, Sayed AM. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population. Vaccines (Basel). 2022;10(1):109. [DOI] [PMID] [PMCID]
14. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-207. [DOI] [PMID] [PMCID]
15. Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, et al. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan : A Randomized , Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. Vaccines (Basel). 2021;9(6):556. [DOI] [PMID] [PMCID]
16. El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, et al. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents : A Retrospective Cross-Sectional Study. Int J Gen Med. 2021;14:1389-401. [DOI] [PMID] [PMCID]
17. Abdollahi A, Naseh I, Kazemi-Galougahi MH, Kalroozi F, Nezamzadeh M, Feyzollahi M, et al. Comparison of four types of vaccines Sinopharm, AstraZeneca, Sputnik V, and Covaxin in terms of morbidity and severity of COVID-19 in vaccinated personnel of several selected medical centers, Tehran, Iran. Int J Med Investig. 2022;11(2):56-65. [Article]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
